Go back

FP7 Cooperation: innovative medicines initiative

The European Commission Framework Programme 7: Cooperation, under its innovative medicines initiative, and with funding from the European Federation of Pharmaceutical Industries and Associations, invites applications for its eighth joint call for expressions of interest.

The topics for this call are: conduct of clinical trials supporting the development of MEDI4893, a monoclonal antibody targeting Staphylococcus aureus alpha toxin; discovery and development of new drugs combating Gram-negative infections; approaches to develop a new classification for systemic lupus erythematosus and related connective tissue disorders and rheumatoid arthritis; approaches to develop a new classification for neurodegenerative disorders with a focus on Alzheimer’s disease and Parkinson’s disease; European induced pluripotent stem cell bank.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.